top of page
Lipid Nanoparticle Overview
Application Note
Lipid nanoparticles (LNPs) stand as the most advanced non-viral gene delivery system within clinical practice. They have proven their capability to safely and efficiently transport nucleic acids, addressing a significant obstacle that previously hindered the progress and utilization of genetic medicines. Genetic medicine encompasses various applications, including gene editing, the expedited development of vaccines, immuno-oncology, and the treatment of rare genetic and previously untreatable diseases. All of these applications have traditionally faced challenges due to inefficiencies in nucleic acid delivery.
Lipid Nanoparticles (LNPs) are a class of nanoscale delivery systems designed to transport and protect therapeutic molecules, such as drugs and RNA, to specific target sites within the body. They have gained significant attention in the field of medicine and biotechnology due to their ability to enhance the bioavailability and efficacy of drugs by improving stability and ability to target points of interest for drug delivery. The basic structure of an LNP consists of a lipid bilayer surrounding a hydrophobic core. This structure allows the LNPs to encapsulate hydrophobic drugs or nucleic acids within the core while keeping the hydrophilic components on the surface, making them stable and compatible with the aqueous environment of the body.
What is LNP?
Working Principle
LNP Formulation & Preparation Protocol
Conventionally, solvent injection and thin film rehydration are two common methods for liposome synthesis. Due to the simplicity of equipment requirements, such as sonicators or rotary evaporators, solvent injection and thin film rehydration methods are widely adopted in both research and production process. However, these traditional methods meet the challenges of low homogeneity of resulted LNPs, hash processes for delicate biomolecules, such as DNAs, RNAs or proteins. To address these challenges, microfluidic mixing method has been rapidly developed in the past decade.
Schematic of oligonucleotide based LNP synthesis
Preparatin Protocol
Payloads
mRNA/siRNA
Proteins and peptides
DNA
Small molecules
Applications
Gene Therapy
Genetic drugs, including small interfering RNA (siRNA), mRNA, or plasmid DNA, hold promise for treating a wide array of diseases by either suppressing harmful genes, producing therapeutic proteins, or employing gene-editing techniques. Currently, lipid nanoparticle (LNP) systems stand at the forefront among non-viral delivery methods, enabling the clinical utilization of genetic drugs.
Vaccines
Lipid nanoparticle has played a pivotal role in expediting the development of vaccines, as demonstrated by Pfizer and Moderna in the COVID-19 pandemic response. It allows for precise and high-throughput screening of potential vaccine candidates. The technology facilitates rapid testing, antigen formulation, and optimization of vaccine delivery systems.
Cell Therapy
Cell Therapies entail the transformation of cells, commonly immune cells, obtained either from the patient (autologous) or a compatible donor (allogeneic). These modified cells undergo isolation, amplification, and are later reintroduced into the patient. Lipid Nanoparticles (LNPs) present a versatile approach to cell reprogramming, facilitating the transfer of RNA responsible for protein expression or gene editing.
Other Areas
Other applications including cosmetics, medical imaging, nutrition, agrochemicals, etc.
The cosmetics sector stood at the forefront in acknowledging and utilizing nanotechnology advancements in diverse product innovations. Liposomal cosmetic formulations are expected to offer several benefits, including improved stability and effectiveness, along with successful ingredient penetration into the skin. A variety of liposomal cosmetics are currently in use.
Introduction Videos and Webinars:
LNP Introduction
NanoGenerator™ LNP Synthesis & Application Webinar with ProMab Biotechnologies
Introduction Videos
bottom of page